Philippine Regional Court Denies Patent Protection For Pfizer Drug
This article was originally published in PharmAsia News
Executive Summary
A Philippine regional court denied U.S.-based Pfizer's attempt to block a United Laboratories launch of a generic version of Caduet (atorvastatin) for treating hypertension